Display options
Cite
Winckler S, Overbeck JP, Meffert R, et al. Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis. Eur J Orthop Surg Traumatol. 1995;5(2):133-7doi: 10.1007/BF02716257.
Winckler, S., Overbeck, J. P., Meffert, R., Törmälä, P., & Spiegel, H. U. (1995). Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 5(2), 133-7. https://doi.org/10.1007/BF02716257
Winckler, S, et al. "Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis." European journal of orthopaedic surgery & traumatology : orthopedie traumatologie vol. 5,2 (1995): 133-7. doi: https://doi.org/10.1007/BF02716257
Winckler S, Overbeck JP, Meffert R, Törmälä P, Spiegel HU. Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis. Eur J Orthop Surg Traumatol. 1995 Dec;5(2):133-7. doi: 10.1007/BF02716257. PMID: 24193334.
Copy Download .nbib Format: NLM
Share it on

Eur J Orthop Surg Traumatol. 1995 Dec;5(2):133-7. doi: 10.1007/BF02716257.

Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

S Winckler, J P Overbeck, R Meffert, P Törmälä, H U Spiegel

Affiliations

  1. Department of Trauma- and Hand Surgery, Westfälische Wilhelms-Universität, D-48149, Münster, Germany.

PMID: 24193334 DOI: 10.1007/BF02716257

Abstract

Polyglycolic test cylinders (PGA) of different sizes and with a different amount of Ciprofloxacin were synthezised and tested in vitro. The monofil 3,2×5 mm sized cylinders containing 3 mg of Ciprofloxacin showed the best release of the antibiotic up to half a year (measured by HPLC). In vivo setting: in the right femur of 66 rabbits osteomyelitis was induced by injection of 3×10(6) cfu of staph, aureus after the bone marrow had been sclerosed with sodium morrhuate 5%. Two weeks later test cylinders were implanted into the femoral shaft of 30 animals. Thirty-six animals served as controls. Criteria evaluated: weight change, laboratory findings, microbiological, radiological and histopathological parameters. The concentration of Ciprofloxacin was measured in serum, urine and wound secretion by HPLC. All animals developed osteomyelitis. Swabs from the marrow of all treated animals were sterile. The histopathological findings in the control group showed the mild or strong chronic-persistent form of osteomyelitis. In the therapy group even after 2 weeks we mainly found the the chronic-fibrous form. The test-cylinders were well tolerated in the marrow. Levels of the drug were measured in serum, urine and wound secretion.

References

  1. Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S179-83 - PubMed
  2. Oral Surg Oral Med Oral Pathol. 1974 Jan;37(1):142-52 - PubMed
  3. Am J Med. 1987 Apr 27;82(4A):2-11 - PubMed
  4. Unfallchirurg. 1989 Sep;92(9):459-70 - PubMed
  5. Arch Orthop Trauma Surg. 1979 Oct;95(1-2):65-70 - PubMed
  6. J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20 - PubMed
  7. J Infect Dis. 1970 Nov;122(5):410-8 - PubMed
  8. Unfallchirurgie. 1986 Jun;12(3):128-31 - PubMed
  9. Am J Med. 1987 Apr 27;82(4A):33-9 - PubMed

Publication Types